In vivo efficacy and safety of artemether-lumefantrine and amodiaquine-artesunate for uncomplicated Plasmodium falciparum malaria in Mozambique, 2018
Malar. j. (Online); 20 (1), 2021
Artemisinin-based combination therapy (ACT) has been the recommended first-line treatment for uncomplicated malaria in Mozambique since 2006, with artemether-lumefantrine (AL) and amodiaquine-artesunate (AS-AQ) as the first choice. To assess efficacy of currently used ACT, an in vivo therapeutic efficacy...
Amodiaquine, Antimalarials/therapeutic use, Drug Combinations, Antimalarials/standards, Parasitemia, Treatment Outcome, d0082880, Artemether, Lumefantrine Drug Combination/pharmacology, Artemether, Lumefantrine Drug Combination/therapeutic use, Malaria, Falciparum/therapy, Parasitemia/drug therapy, Mozambique/epidemiology